Acerca de nosotros
Bienvenido a Zeta Pharma
Zeta Pharma es una empresa egipcia de rápido crecimiento que se estableció en 2010 para representar un valor añadido en la industria farmacéutica.
Zeta Pharma tenía una diversidad de productos únicos y bien seleccionados en todas las áreas terapéuticas.
Zeta Pharma ha iniciado sus actividades de comercialización en 2015 sobre los productos para el virus de la hepatitis C (Sofocivir, Zetaciver & Sofocivir Plus).
En colaboración con el Ministerio de Salud de Egipto y el Instituto Egipcio de Investigación Hepática, ZETA PHARMA ha logrado tratar a más de 60.000 pacientes con tasas de curación igual al 95%. Este porcentaje se asimila al de la tasa mundial.
Nuestro objetivo y visión

y visión

Nuestro objetivo
Fábrica de Zeta Pharma
ZETA Pharma maintains one of the broadest quality-products portfolio within the industry and as an optimistic view to the future, the board decided to establish a manufacturing facility comply with the cGMP Standards in 7500 m2 area.
Historia de Zeta
Cool Timeline

2022 launched New 9 Products
1-Nexirozova Launch:
Jan – 2022, Zeta Pharma launched Nexirozova; a new generic of the anti-dyslipidemic molecule Rosuvastatin 5,10,20mg,
2021 Launched New 7 Products
1- Bilastegic Launch:
Jan – 2021, Zeta Pharma launched its new product, Bilastegic the world’s latest and most effective product for allergic diseases,
EBRD Agreement 2020
The European Bank for Reconstruction and Development (EBRD) is providing consultancy studies to Zeta Pharma factory in Egypt to qualify for European GMP accreditation.
2020 Launched New 4 Products
1- Empacoza Lunch:
Zeta Pharma launches “Empacoza” type 2 diabetes medicine in the Egyptian Market, In presence of famous Egyptian professors of Internal medication and endocrinology,
2019 Launched New 5 Products
1- Ancavaz Launch:
Zeta launched Ancavaz -which is indicated as a substitution therapy for the treatment of hypertension and/or stable coronary heart disease,
2018 Launched 4 New Products
1- Nexicure Launch:
12/10/2018
Zeta launched Nexicure Esomeprazole 20/40 mg MUPS tablet,
100 Millions Seha
Interview with Major General Mahmoud Ashmawi, Governor of Qalyubia governorate, and Dr. Hamdi El Tabakh, the Ministry of Health representative in Qalyubia in the launch of the Hepatitis C eradication campaign,
HCV Launch
Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).